Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1500)	3/3/2000 10:03:00 PM
From: rexnine	Respond to of 4974

Rick, 2 out of 4 plus NBSC. Your magic wand still works. Rex

To: scaram(o)uche who wrote (1500)	3/4/2000 10:02:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 4974

A plea for therapeutic help. A member of my church has stage II Hodgkins. Does anyone know of any Phase III open label trials that they have followed that they find very positive based on the data and/or technology, especially non-cytotoxic? (Or possible double blind where there has been a precedent for companionate use?) We live in Carbondale IL, a small town in the midst of an economically depressed, fairly sparely populated area, thus not exactly a center of oncology expertise. Any help will be greatly. Please feel free to reply via public post, private post, or private e-mail (sdavis@midwest.net) Thanks, Scott